Cell adhesion molecules (CAMs) are membrane-bound proteins predominantly expressed in the CNS along principal axonal pathways. CAMs, such as L1CAM, NRCAM, CHL1 and NFASC, play key roles in nervous system development, neural cell differentiation and migration, axonal growth and guidance, myelination, and synapse formation. However, only L1CAM and NFASC have been associated with neurodevelopmental disease.
Here we describe 10 patients from eight families with bi-allelic variants in the neuronal cell adhesion molecule NRCAM, leading to a novel neurodevelopmental syndrome of varying severity, characterized by developmental delay/intellectual disability, hypotonia, peripheral neuropathy and/or spasticity. Computational analyses of NRCAM variants, which mostly cluster in the third fibronectin type III (Fn-III) domain, strongly suggest a deleterious effect on NRCAM protein structure and function, potentially hindering its ability to interact with other proteins. These findings are corroborated by previous in vitro studies of murine Nrcam-deficient cells, revealing abnormal neurite outgrowth, synaptogenesis and formation of nodes of Ranvier on myelinated axons. We performed studies on zebrafish nrcamaΔ mutants, revealing that mutant larvae displayed significantly altered swimming behavior compared to wild type larvae (p<0.03). Moreover, nrcamaΔ larvae displayed a trend towards increased amounts of α-tubulin and 5-HT fibers in the dorsal telencephalon, demonstrating an alteration in white matter tracts and projections.
Taken together, our study provides evidence that bi-allelic NRCAM disruption causes a variable form of a neurodevelopmental disorder, and broadens the knowledge on the role of NRCAM in nervous system development, and the growing role of the cell adhesion molecules family in the nervous system.